EI
AKAO

EAM Investors’s Achaogen Inc AKAO Stock Holding History

EAM Investors’s Portfolio AKAO Stock Details AKAO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-151,522
Closed -$3.29M – 382
2017
Q2 		$3.29M Sell
151,522
-126,045
-45% -$2.88M 0.54% 56
2017
Q1 		$7M Sell
277,567
-155,148
-36% -$3.19M 1.1% 1
2016
Q4 		$5.63M Buy
+432,715
New +$2.97M 0.75% 5

Other funds holding AKAO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

EAM Investors's AKAO Position: Q3 2017 in Review

EAM Investors sold out of Achaogen Inc (AKAO) in Q3 2017, closing a stake of 151,522 shares — an estimated $3.29M sold.

EAM Investors first reported a position in AKAO in Q4 2016 and held it in 3 quarters. The position peaked at $7M in Q1 2017. 96 funds tracked by Wall St. Rank hold AKAO as of Q3 2017.

  • EAM Investors reported no remaining Achaogen Inc position as of Q3 2017 after selling out during the quarter.
  • EAM Investors sold 151,522 Achaogen Inc shares in Q3 2017, an estimated $3.29M.
  • EAM Investors first reported a position in Achaogen Inc in Q4 2016 and held it in 3 quarters.
  • EAM Investors's Achaogen Inc position peaked at $7M in Q1 2017.
  • 96 funds tracked by Wall St. Rank held Achaogen Inc as of Q3 2017.

Based on EAM Investors's 13F filing for Q3 2017, filed 8 Nov 2017.